← Leaderboards
Peter M Howley
Dana-Farber Cancer Inst
$39,809,224
Attributed
$40,308,376
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,308,376 · 18
By mechanism
P30$15,900,059 · 7
R35$7,066,641 · 1
P01$5,933,292 · 3
R01$5,649,932 · 3
R37$3,863,249 · 1
RC1$998,305 · 1
Top collaborators
- Jeffrey Wade Harper2 shared
Others in their field
Top investigators on “Member”
- David R. Weir · University Of Michigan At Ann Arbor$340,329,837
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Barton F Haynes · Duke University$312,190,812
- Jeffrey P Krischer · University Of South Florida$296,624,284
- Norman Wolmark · Nsabp Foundation, Inc.$262,548,790
Research focus
MemberBaseHuman PapillomavirusFundingLaboratoriesCancer CenterInterestDana-Farber Cancer InstituteTumorCancer Center Support GrantProgramsProteinsPapillomavirusMalignant NeoplasmsCollaborationsResearch PersonnelLinkAreaInvestigationMalignant Neoplasm Of Cervix UteriOncoproteinsInstitutionTissuesCells
Grant awards (100)
Developmental Funds$812,006
P30 · FY2025 · CA · contact PI
Developmental Funds$31,074
P30 · FY2025 · CA · contact PI
Developmental Funds$976,973
P30 · FY2024 · CA · contact PI
Developmental Funds$1,014,814
P30 · FY2023 · CA · contact PI
Rodent Histopathology Core$1
P30 · FY2023 · CA · contact PI
Developmental Funds$1,014,814
P30 · FY2022 · CA · contact PI
Molecular Biology of Oncogenic Papillomaviruses$996,660
R35 · FY2022 · CA · contact PI
Rodent Histopathology Core$1
P30 · FY2022 · CA · contact PI
Molecular Biology of Oncogenic Papillomaviruses$1,016,960
R35 · FY2021 · CA · contact PI
Developmental Funds$507,703
P30 · FY2021 · CA · contact PI
Shared Resource 09: Rodent Histopathology$252,582
P30 · FY2021 · CA · contact PI
Molecular Biology of Oncogenic Papillomaviruses$1,017,000
R35 · FY2020 · CA · contact PI
Developmental Funds$507,590
P30 · FY2020 · CA · contact PI
Shared Resource 09: Rodent Histopathology$252,469
P30 · FY2020 · CA · contact PI
Developmental Funds$2,950
P30 · FY2020 · CA · contact PI
Shared Resource 09: Rodent Histopathology$2,949
P30 · FY2020 · CA · contact PI
Molecular Biology of Oncogenic Papillomaviruses$985,021
R35 · FY2019 · CA · contact PI
Developmental Funds$505,959
P30 · FY2019 · CA · contact PI
Shared Resource 09: Rodent Histopathology$250,838
P30 · FY2019 · CA · contact PI
Developmental Funds$6,169
P30 · FY2019 · CA · contact PI
Shared Resource 09: Rodent Histopathology$6,168
P30 · FY2019 · CA · contact PI
Molecular Biology of Oncogenic Papillomaviruses$1,017,000
R35 · FY2018 · CA · contact PI
Developmental Funds$507,620
P30 · FY2018 · CA · contact PI
Shared Resource 09: Rodent Histopathology$252,499
P30 · FY2018 · CA · contact PI
Shared Resource 09: Rodent Histopathology$11,431
P30 · FY2018 · CA · contact PI
Developmental Funds$11,431
P30 · FY2018 · CA · contact PI
Developmental Funds$5,850
P30 · FY2018 · CA · contact PI
Shared Resource 09: Rodent Histopathology$5,849
P30 · FY2018 · CA · contact PI
Developmental Funds$5,124
P30 · FY2018 · CA · contact PI
Shared Resource 09: Rodent Histopathology$5,123
P30 · FY2018 · CA · contact PI
Shared Resource 09: Rodent Histopathology$3,835
P30 · FY2018 · CA · contact PI
Developmental Funds$3,835
P30 · FY2018 · CA · contact PI
Shared Resource 09: Rodent Histopathology$1,603
P30 · FY2018 · CA · contact PI
Developmental Funds$1,603
P30 · FY2018 · CA · contact PI
Molecular Biology of Oncogenic Papillomaviruses$1,017,000
R35 · FY2017 · CA · contact PI
Developmental Funds$524,999
P30 · FY2017 · CA · contact PI
Shared Resource 09: Rodent Histopathology$258,874
P30 · FY2017 · CA · contact PI
Molecular Biology of Oncogenic Papillomaviruses$1,017,000
R35 · FY2016 · CA · contact PI
Rodent Histopathology$221,079
P30 · FY2016 · CA · contact PI
Papillomavirus E2 Functions: Cellular Regulation and Effectors$316,541
R01 · FY2015 · CA · contact PI
Rodent Histopathology$221,291
P30 · FY2015 · CA · contact PI
Papillomavirus E2 Functions: Cellular Regulation and Effectors$307,044
R01 · FY2014 · CA · contact PI
Small Molecule Screen Targeting p53 proteolysis in HPV positive cancers$221,615
R21 · FY2014 · CA · contact PI
Rodent Histopathology$210,838
P30 · FY2014 · CA · contact PI
Papillomavirus E2 Growth Suppression Mechanisms$525,651
P01 · FY2013 · CA · contact PI
Papillomavirus E2 Functions: Cellular Regulation and Effectors$297,549
R01 · FY2013 · CA · contact PI
Rodent Histopathology$203,696
P30 · FY2013 · CA · contact PI
Small Molecule Screen Targeting p53 proteolysis in HPV positive cancers$195,391
R21 · FY2013 · CA · contact PI
Papillomavirus E2 Growth Suppression Mechanisms$563,118
P01 · FY2012 · CA · contact PI
Papillomavirus E2 Functions: Cellular Regulation and Effectors$315,608
R01 · FY2012 · CA · contact PI
Rodent Histopathology$220,983
P30 · FY2012 · CA · contact PI
Papillomavirus E2 Growth Suppression Mechanisms$567,154
P01 · FY2011 · CA · contact PI
Development$1,560,270
P30 · FY2010 · CA · contact PI
Papillomavirus E2 Growth Suppression Mechanisms$586,502
P01 · FY2010 · CA · contact PI
Oncogenic Human Papillomavirus Protein Network$498,305
RC1 · FY2010 · CA · contact PI
Mechanistic Analysis of Papillimavirus E2 Functions$262,923
R01 · FY2010 · CA · contact PI
Development$1,647,550
P30 · FY2009 · CA · contact PI
Papillomavirus E2 Growth Suppression Mechanisms$574,098
P01 · FY2009 · CA · contact PI
Oncogenic Human Papillomavirus Protein Network$500,000
RC1 · FY2009 · CA · contact PI
Mechanistic Analysis of Papillimavirus E2 Functions$264,075
R01 · FY2009 · CA · contact PI
Mechanistic Analysis of Papillimavirus E2 Functions$262,923
R01 · FY2009 · CA · contact PI
Development$1,550,634
P30 · FY2008 · CA · contact PI
Cellular Targets of Papillomavirus Oncoproteins$582,125
P01 · FY2008 · CA · contact PI
Mechanistic Analysis of Papillimavirus E2 Functions$262,923
R01 · FY2008 · CA · contact PI
Development$1,668,499
P30 · FY2007 · CA · contact PI
Cellular Targets of Papillomavirus Oncoproteins$579,048
P01 · FY2007 · CA · contact PI
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$550,839
R37 · FY2007 · CA · contact PI
The Roles of IRF-3 in the Cellular Response to Viral Infection$321,433
R01 · FY2007 · AI · contact PI
Mechanistics Analysis of Papillomavirus E2 Functions$262,923
R01 · FY2007 · CA · contact PI
Development$650,483
P30 · FY2006 · CA · contact PI
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$552,306
R37 · FY2006 · CA · contact PI
Cellular Targets of Papillomavirus Oncoproteins$412,990
P01 · FY2006 · CA · contact PI
The Roles of IRF-3 in the Cellular Response to Viral Inf$331,034
R01 · FY2006 · AI · contact PI
Mechanistic Analysis of Papillimavirus E2 Functions$270,776
R01 · FY2006 · CA · contact PI
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$556,619
R37 · FY2005 · CA
Cellular Targets of Papillomavirus Oncoproteins$402,971
P01 · FY2005 · CA
The Roles of IRF-3 in the Cellular Response to Viral Inf$339,000
R01 · FY2005 · AI
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$459,312
R37 · FY2004 · CA
Cellular Targets of Papillomavirus Oncoproteins$390,887
P01 · FY2004 · CA
The Roles of IRF-3 in the Cellular Response to Viral Inf$338,000
R01 · FY2004 · AI
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$461,543
R37 · FY2003 · CA
IRF-3 in the Cellular Response to Viral Infection$336,000
R01 · FY2003 · AI
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$78,154
R37 · FY2003 · CA
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$426,641
R37 · FY2002 · CA
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION$318,779
R01 · FY2002 · CA
CELLULAR TARGETS FOR PAPILLOMAVIRUS E6 ONCOPROTEINS$228,401
P01 · FY2002 · CA
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION$76,975
R01 · FY2002 · CA
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$45,112
R37 · FY2002 · CA
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$371,437
R37 · FY2001 · CA
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION$310,658
R01 · FY2001 · CA
PROGRAM IN CANCER BIOLOGY$253,800
T32 · FY2001 · CA
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION$72,608
R01 · FY2001 · CA
CELLULAR TARGETS FOR PAPILLOMAVIRUS E6 ONCOPROTEINS$0
P01 · FY2001 · CA
FUNCTIONAL ANALYSIS OF THE E6AP UBIQUITIN PROTEIN LIGASE$361,286
R37 · FY2000 · CA
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION$302,775
R01 · FY2000 · CA
CELLULAR TARGETS FOR PAPILLOMAVIRUS E6 ONCOPROTEINS$283,979
P01 · FY2000 · CA
MECHANISMS OF IMMUNE EVASION BY PAPILLOMAVIRUS$236,368
P01 · FY2000 · AI
PROGRAM IN CANCER BIOLOGY$226,092
T32 · FY2000 · CA
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION$66,041
R01 · FY2000 · CA
MECHANISM OF HPV E2 MEDIATED CELLULAR GROWTH SUPPRESSION$13,344
R01 · FY2000 · CA